IV Antibiotics for Complicated Cystitis

Understanding Complicated Cystitis

• The European Association of Urology recommends that complicated cystitis occurs when host-related factors or anatomic/functional urinary tract abnormalities make infection harder to eradicate, including multidrug-resistant organisms 1
• The microbial spectrum is broader than uncomplicated UTIs, with E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. being most common, and antimicrobial resistance is more likely 1

First-Line IV Antibiotic Regimens

• The European Urology guidelines recommend ceftriaxone 1-2 g IV daily for complicated cystitis 1
• The European Urology guidelines recommend piperacillin-tazobactam 2.5-4.5 g IV three times daily for complicated cystitis 1
• The European Urology guidelines recommend ciprofloxacin 400 mg IV twice daily for complicated cystitis if susceptible 1
• The European Urology guidelines recommend levofloxacin 750 mg IV daily for complicated cystitis if susceptible 1
• The European Urology guidelines recommend gentamicin 5 mg/kg IV daily for complicated cystitis 1
• The European Urology guidelines recommend amikacin 15 mg/kg IV daily for complicated cystitis 1

Treatment Duration and Transition Strategy

• The European Urology guidelines recommend a total antibiotic duration of 7-10 days for complicated cystitis 1
• The European Urology guidelines recommend transitioning from IV to oral therapy after clinical improvement, typically within 3 days 1

Reserve Agents for Multidrug-Resistant Organisms

• The European Urology guidelines recommend carbapenems and novel broad-spectrum agents only when early culture results indicate multidrug-resistant organisms 1
• The European Urology guidelines recommend imipenem/cilastatin 0.5 g IV three times daily for multidrug-resistant organisms 1
• The European Urology guidelines recommend meropenem 1 g IV three times daily for multidrug-resistant organisms 1
• The European Urology guidelines recommend ceftolozane/tazobactam 1.5 g IV three times daily for multidrug-resistant organisms 1
• The European Urology guidelines recommend ceftazidime/avibactam 2.5 g IV three times daily for multidrug-resistant organisms 1
• The European Urology guidelines recommend cefiderocol 2 g IV three times daily for multidrug-resistant organisms 1
• The European Urology guidelines recommend meropenem-vaborbactam 2 g IV three times daily for multidrug-resistant organisms 1

Critical Management Principles

• The European Urology guidelines recommend addressing the underlying urological abnormality or complicating factor as mandatory for successful treatment 1
• The European Urology guidelines recommend obtaining urine culture with susceptibility testing before initiating therapy to guide antibiotic selection 1
• The European Urology guidelines recommend basing empirical therapy on local resistance patterns and optimizing based on culture results 1

Common Pitfalls to Avoid

• The European Urology guidelines recommend avoiding the use of carbapenems empirically without culture evidence of multidrug-resistant organisms to prevent further resistance 1
• The European Urology guidelines recommend addressing anatomic abnormalities to prevent treatment failure regardless of antibiotic choice 1
• The European Urology guidelines recommend obtaining cultures in complicated UTI to optimize therapy and detect resistant organisms 1
• The European Urology guidelines recommend avoiding the use of fluoroquinolones empirically when other options are available to prevent resistance 1